Markers in Early Breast Cancer
Author Information
Author(s): Jahkola T, Toivonen T, Smitten K von, Virtanen I, Wasenius V-M, Blomqvist C
Primary Institution: Helsinki University Central Hospital
Hypothesis
The study aims to investigate the distribution of cathepsin-D, urokinase plasminogen activator, and type-1 plasminogen activator inhibitor in early breast cancer and their relation to prognostic factors.
Conclusion
Immunohistochemical determination of cathepsin-D is a viable method to predict a higher risk of metastasis in small axillary node-negative breast carcinomas.
Supporting Evidence
- Cytoplasmic immunoreactivity for cathepsin-D was seen in carcinoma cells in 47% of cases.
- Nearly all tumors expressed uPA and PAI-1.
- Stromal cathepsin-D was identified as an independent prognostic factor for metastasis.
- Stromal expression of uPA was associated with an increased risk of local recurrence.
Takeaway
The study looked at certain markers in breast cancer to see if they could help predict if the cancer would spread. They found that one marker, cathepsin-D, could help tell if the cancer might come back.
Methodology
The study used immunohistochemistry to analyze the expression of specific markers in breast cancer tissues.
Limitations
No consistent association was found between uPA and PAI-1 and prognosis.
Participant Demographics
All participants were women with small axillary node-negative breast carcinomas.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website